FDA 1571 Investigational New Drug Application

Investigational New Drug Regulations

FDA-1571 updates

CBER: Part 312 Subpart A - General Provisions; including applicability of requirements and requests for waivers

OMB: 0910-0014

Document [html]
Download: html
Error

An error occurred.

Sorry, the page you are looking for is currently unavailable.
Please try again later.

If you are the system administrator of this resource then you should check the error log for details.

Faithfully yours, nginx.

File Typetext/html

© 2025 OMB.report | Privacy Policy